Everything on Business/Healthcare Strategy

The primary cause of cancer drug failure in clinical trials is poor patient selection rather than deficiencies in pharmacology or molecule design.

Impact: Shifts R&D investment from target discovery toward the development of high-precision patient stratification tools.

— from AI Foundation Models and the Future of Precision Oncology · Latent Space: The AI Engineer Podcast· Apr 20, 2026